Dorman A M, Walsh T N, Droogan O, Curran B, Hourihane D O, Hennessy T P, Leader M
Department of Histopathology, Royal College of Surgeons, Dublin.
Cytometry. 1992;13(8):886-92. doi: 10.1002/cyto.990130812.
This is the first comparative study of DNA quantification of oesophageal squamous cell carcinoma by flow cytometry (FCM) and image cytometry (ICM) using formalin fixed paraffin embedded tissue. The potential advantages of ICM include the identification of a reliable control cell population; avoidance of non-tumour stromal and inflammatory cell nuclei, nuclear fragments, degenerate cell nuclei and doublets, triplets etc., which are not possible with FCM using archival tissue. Twenty-eight cases, all of the same stage (stage 2a) and similar grade (well or moderately differentiated) were analysed. The cases were separated into two groups, those that had succumbed to tumour in less than 18 months (group A) and those that were tumour free at least 18 months post-resection (group B). Using ICM all 28 tumours yielded interpretable histograms by comparison to 25 of 28 using FCM. Aneuploidy was identified in 100% of cases in group A using ICM (in comparison to 73% by FCM) and in 73% of group B using ICM (in comparison to 44% by FCM). Any tumour aneuploid by FCM was also aneuploid by ICM. Nine cases aneuploid by ICM were euploid by FCM. The mean 5C exceeding rate (% of cells whose nuclei contain a DNA mass equivalent to > 5 sets of 23 chromosomes) was 21% in group A and 14% in group B (P < 0.01). Euploidy was confined to tumours of those patients disease free for more than 18 months. The conclusions of this study are that: firstly, ICM is superior in its yield of interpretable histograms to FCM using formalin fixed paraffin embedded tissue; secondly, ICM is more sensitive in the identification of aneuploid stemlines than FCM; and thirdly, euploid tumours (as detected by ICM) appear to have a better prognosis than aneuploid tumours of similar stage and grade.
这是第一项使用福尔马林固定石蜡包埋组织,通过流式细胞术(FCM)和图像细胞术(ICM)对食管鳞状细胞癌进行DNA定量的比较研究。ICM的潜在优势包括识别可靠的对照细胞群体;避免非肿瘤性基质和炎性细胞核、核碎片、退化细胞核以及双核、三核等,而使用存档组织进行FCM检测时则无法避免这些情况。对28例处于同一阶段(2a期)且分级相似(高分化或中分化)的病例进行了分析。这些病例被分为两组,一组是在不到18个月内死于肿瘤的患者(A组),另一组是切除术后至少18个月无肿瘤的患者(B组)。使用ICM时,所有28个肿瘤均产生了可解释的直方图,而使用FCM时,28个肿瘤中只有25个产生了可解释的直方图。使用ICM时,A组100%的病例被鉴定为非整倍体(相比之下,FCM检测为73%),B组73%的病例被鉴定为非整倍体(相比之下,FCM检测为44%)。任何通过FCM检测为非整倍体的肿瘤,通过ICM检测也为非整倍体。有9例通过ICM检测为非整倍体的肿瘤,通过FCM检测为整倍体。A组的平均5C超标率(细胞核中DNA含量相当于>5组23条染色体的细胞百分比)为21%,B组为14%(P<0.01)。整倍体仅限于那些无病超过18个月患者的肿瘤。本研究的结论是:首先,使用福尔马林固定石蜡包埋组织时,ICM产生可解释直方图的成功率高于FCM;其次,ICM在识别非整倍体干细胞系方面比FCM更敏感;第三,(通过ICM检测到的)整倍体肿瘤似乎比相同阶段和分级的非整倍体肿瘤预后更好。